• Correlate Infrastructure Partners is known for executing portfolio-scale renewable energy and efficiency upgrades across the U.S.
• With a recent study observing that more CEOs are now prioritizing sustainability, the market is clearly growing for Correlate’s services
• Correlate helps companies deal with some of the key challenges identified in the study, including concerns about the return on investment and economic benefits, lack of insights from data, inadequate skills, and general technological barriers
• Correlate funds, designs, engineers, and builds sustainability-focused projects in addition to providing the technical expertise through its team of energy experts, and in a way that makes sustainability compellingly affordable

Sustainability is increasingly gaining prominence as part of the mainstream corporate agenda. A recent study by the Institute for Business Value (“IBV”), a think tank that is part of IBM Corporation (NYSE: IBM), notes that “CEOs who successfully integrate sustainability and digital transformation report a higher average operating margin than their peers.” The IBV study, which drew insights from interviews with 3,000 CEOs from over 40 countries, showed that 37% more CEOs in 2022 than in 2021 consider sustainability a top priority. More significantly, 83% anticipate sustainability investments will yield improved business results in the next half a decade (https://ibn.fm/m348T). The CEOs, however, mentioned a number of hurdles that could hinder the achievement of their sustainability objectives. Chief among the challenges cited by most CEOs, 57%, is the unclear return on investment (“ROI”) and economic benefits of sustainability investments. Others include regulatory and technological barriers, lack of clear insights from data, and inadequate skills for moving forward. The study, nonetheless, singled out strategy, committed leadership, and strategic partnerships, as some of the key drivers and differentiators that could enable companies to deal with these hurdles and attain sustainability. “Solving the world’s most vexing social and environmental problems demands strategic collaboration and innovative approaches within and across industries,” an excerpt from the report reads (https://ibn.fm/l6cOX). In Correlate Infrastructure Partners (OTCQB: CIPI), a company with an extensive track record in executing portfolio-scale renewable energy and comprehensive efficiency upgrades across the United States, CEOs looking to solve social and environmental problems find that strategic partner and innovator. With Correlate, the company’s website notes, sustainability and profitability are no longer at odds. CIPI makes it far easier for organizations to attain their Environmental, Social, and Governance (“ESG”) and Net Operating Income (“NOI”) goals. This is accomplished through a low-cost model that minimizes risk and guarantees value, greatly reducing the wasting of time and money. With executives citing ROI and economic benefits as some of the major hurdles to sustainability investment, it’s a major selling point that Correlate’s funding mechanisms for renewable energy projects and efficiency upgrades deal directly with these concerns. “Our funding mechanisms don’t require out-of-pocket capital expenditures (“CapEx”). Because our solutions are cash flow positive, you can rapidly capture the full value of opportunities and increase net operating income,” CIPI’s website reads. Important as it is, funding is just one of the benefits client companies realize by partnering with Correlate. Others include unsurpassed technical expertise when it comes to efficient technological solutions and analytics. CIPI relies on a team of energy experts to develop a customized operating strategy that fits each organization’s portfolio. This team utilizes analytics that combines the clients’ facility and utility data and their corporate energy goals, creating a clear and useful foundation that helps them identify the most impactful measures affecting NOI when solutions are installed or deployed. CIPI designs, engineers, and builds the projects, collaborating with its clients’ existing partners to ensure that all parties are working efficiently toward the same goal. Correlate deploys its software platform, which monitors, measures, and optimizes numerous building performance metrics before, during, and after the completion of the installations and upgrades to identify energy improvement opportunities. The market for Correlate’s services appears set for healthy expansion, consistent with industry reports. Analysts at Reports and Insights, for instance, project that the energy-efficient building market will grow from a value of $235.7 billion in 2020 to $476.4 billion by 2028, representing a 9.2% CAGR (https://ibn.fm/4EnEr). At the same time, a market outlook report by Allied Market Research estimates the global renewable energy market will expand at a CAGR of 8.4% from 2021 to 2030. This growth will see the value increase from $881.7 billion in 2020 to an estimated $1.978 trillion by 2030 (https://ibn.fm/8dyVR). For more information, visit the company’s website at www.CorrelateInfra.com.

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• The company’s platform Generates New Rent and Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

For more information, visit the company’s website at www.CorrelateInfra.com. NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Biopharma industry analysts have been expecting 2022 to be a heady year for big-pharma acquisitions or partnerships with promising medical upstarts following a time period that has left the biggest companies flush with cash
• Among promising device and drug developers, Odyssey Health Inc. has been working on novel solutions to brain concussion injuries, a rare neurodegenerative disease, obstructive choking incidents and early-stage coronary artery disease (“CAD”) detection
• Odyssey Health Inc. is taking its brain concussion solution to a Phase 1 clinical human trial currently with possible progression to Phase 2 before the end of the year
• The company likewise anticipates it could advance its two device products for FDA submission by year’s end and on to potential commercial development

As 2022 got under way, the biopharma world was trying to predict where the major acquisitions for the year would take place and how much would be spent on M&A, given the cash-flush environment of big-pharma, particularly for those successful in responding to COVID-19, and the patent cliffs many of those companies are facing (https://ibn.fm/IUXaV). Halfway through the year, deal values are down by 58 percent and volume has decreased by 33 percent, according to professional services firm PwC. And yet the company’s analysts are continuing to predict a flurry of activity will bring equilibrium to industry outlooks by year’s end as big-pharma hunts for biotechs focus on early-stage companies and bolt-on transactions (https://ibn.fm/Hc5rS). That class of deals is exemplified by recent M&A efforts by Pfizer to acquire migraine therapy innovator Biohaven (https://ibn.fm/NBS7x) and partner with “mystery startup” Priovant, an autoimmune disease biotech unit of Roivant (https://ibn.fm/FasFg), while Bristol Myers Squibb is dealing with the adoption of cancer drug maker Celgene (https://ibn.fm/BPHlG). Medical device innovator and biopharmaceutical product developer Odyssey Health (OTC: ODYY) is optimistic about the trend as the company continues to dedicate its operational strategy toward the acquisition and creation of lifesaving medical products. Odyssey’s portfolio includes medical device candidates and pharmaceutical products in development that are responsive to conditions such as heart disease, foreign object-induced choking, neurodegenerative disorders and brain concussion injuries. One drug product designed to treat mild traumatic brain injury within the first few minutes after an incident is advancing in a Phase 1 clinical human trial following on preclinical lab animal tests that provided encouraging data, CEO Michael Redmond said in a June interview (https://ibn.fm/QCCH4). No U.S. Food and Drug Administration (“FDA”)-approved drug exists at this point, creating a particular opportunity for the company. The other drug substance is a novel compound intended to treat neurodegenerative Niemann-Pick disease, which leaves patients with an average lifespan of five to 20 years beyond diagnosis. The company’s device technology includes a monitoring and screening device for early detection of coronary artery disease and a handheld choking rescue device (https://ibn.fm/MUhfe). “We could be in commercial — with proper funding and if we meet our technical goals — we could be into the FDA by the end of this year with both of those products,” Redmond said. For more information, visit the company’s website at https://odysseygi.com/. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

• Lexaria is a global innovator in drug delivery platforms; its patented DehydraTECH(TM) technology improves the bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“API”)
• Testing confirms that DehydraTECH-processed cannabidiol beverages maintained 93.4% and 78% potency of CBD a full year and two years after production, respectively
• Lexaria recently signed two agreements with BevNology LLC, an Atlanta-based company with advanced capabilities that support best-in-class beverage formulations
• The partnership, which also leverages Lexaria’s superior DehydraTECH-CBD nanoemulsification formulation and processing techniques, could make industry-leading beverage products a reality for many brands

In this year’s letter to shareholders, Lexaria Bioscience (NASDAQ: LEXX) Chair and CEO Chris Bunka acclaimed the company’s research and development achievements which had resulted in remarkable stability of DehydraTECH(TM)-processed cannabidiol (“CBD”) beverages. One year after production, Bunka wrote, “bottled consumer beverage contained a remarkable 93.4% potency of CBD. We also showed less than 1% variability of CBD potency within the beverage, a concept of critical importance when delivering drugs in an aqueous solution” (https://ibn.fm/uhiIf). The latest data from stability testing undertaken 25 months after initial bottling show the product had higher variability but still retained an average 78% of originally formulated CBD. Additionally, the microbiologic purity and cleanliness of the product surpassed all requirements 25 months after bottling. One problem that has long caused the instability and variability of cannabis drinks, which normally include cannabinoids such as CBD and tetrahydrocannabinol (“THC”), is the hydrophobic nature of the cannabinoids. When THC or CBD are extracted from the cannabis or plant, they take an oil-based form. And as a Prepared Foods article notes, this hydrophobic nature complicates their use, particularly in water-based products. Studies have, in fact, shown that the insolubility of CBD, for instance, results in bioavailability as low as 4%. But companies can get around this problem using adequate manufacturing techniques that employ encapsulation and emulsification (https://ibn.fm/sanbV). “First and foremost, encapsulation allows for even dispersion throughout the product, meaning consumers will get the same amount of an active ingredient, such as CBD or THC, in each bite or sip,” reads the Prepared Foods article. “Encapsulation also improves a product’s shelf life, preventing the cannabinoid content from degrading over time and keeping the formulation stable.” On the other hand, emulsification, which involves using a binding agent known as an emulsifier, aims to improve the absorption and onset times. There are three types of oil-in-water emulsions, macro, micro, and nano, with nanoemulsions featuring prominently in the cannabis food and beverage industry. Lexaria understands the impact of adequate manufacturing techniques on the potency of its DehydraTECH-processed CBD products. And in a recent move that expands its manufacturing prowess even further, the company recently signed two agreements with BevNology LLC, a leading Atlanta-based beverage development and advisory company focused on providing quality formulation and commercialization services of cutting-edge beverage products (https://ibn.fm/pJVrz). One of these agreements, a manufacturing operating agreement, expands production capabilities for Lexaria’s own growing list of business-to-business (“B2B”) clients looking to purchase DehydraTECH-powered active ingredients for consumer-packaged-goods brands. BevNology custom-built a new, state-of-the-art processing facility that expands production capacity substantially. Already, the facility is operational and serving Lexaria’s clients. On its part, Lexaria installed all required commercial DehydraTECH manufacturing equipment into the facility in anticipation of future growth. Meanwhile, the second agreement, a commercial license agreement, authorizes BevNology to offer DehydraTECH products with hemp-derived active ingredients, including CBD, under BevNology and partnered brands. This agreement leverages BevNology’s advanced capabilities that support best-in-class beverage formulations coupled with Lexaria’s superior DehydraTECH-CBD nanoemulsification formulation and processing techniques, could make industry-leading beverage products a reality for many brands. “These agreements build on a long-standing and very successful product development consulting relationship between Lexaria and the expert scientists and personnel at BevNology,” commented Chris Bunka. “BevNology’s formulation and production capabilities are class leading, and we are confident that our new relationship with our trusted partner will propel new and exciting growth opportunities for both companies.” Lexaria Bioscience is a global innovator in drug delivery platforms, its patented DehydraTECH technology improves the bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“API”). For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• U.S.-based mobile communications technology services provider FingerMotion is a China-focused innovator building revenues in the cell phone and reinsurance markets
• China recently reinforced its interest in seeing mobile payments and financial technology platforms playing a larger part in its developing economic strategy for strengthening its internal domestic consumerism
• FingerMotion recently reported annual financial data that showed revenue had grown by 37 percent during last year with 297 percent growth in its big data revenue and 170 percent growth in telecommunications products and services
• China has an estimated 1.4 billion mobile users, and market analysts predict mobile engagement there will grow at a CAGR of 44.7 percent between 2020 and 2027

Evolving mobile technology services provider FingerMotion (NASDAQ: FNGR) is building a deeper channel for revenue in its services for China’s mobile phone users and big data clients as the nation’s government signals new interest in finding solutions to some of its regulatory concerns for the market in general. China President Xi Jinping recently encouraged mobile payments and financial technology platforms to “play a bigger role” in strengthening the country’s economy, which is the second-largest in the world (https://ibn.fm/mlTwA). The technology platforms are viewed as key players in supporting the country’s dual circulation economic goal — a new buzzword that describes the nation’s growing emphasis on strengthening its domestic consumer market while continuing to sustain its international exports (https://ibn.fm/I3hhy). FingerMotion’s central competencies are in mobile payment and mobile recharge platform solutions, but the company has been expanding into big data services through its Sapientus division. The data services have primarily been marketed as a tool for reinsurance companies as they they look for effective measures of risk scoring and ways to simplify policy underwriting purchasing, but FingerMotion has acknowledged it could expand into other industries at some in the future. “We’ve always thought of the ability of the algorithms that we have. It’s not really just to perfect those algorithms but it’s also to have them exportable and replicated in other jurisdictions, in other markets,” CEO Martin Shen said during a corporate conference call last year (https://ibn.fm/LbDcC). “But again, that takes time to develop. … Right now, let’s just build and make sure that our foundation is strong first.” The year-end financial summary presented by FingerMotion in early June showed annual revenue had grown by 37 percent during last year to $22.93 million, with 170 percent growth in the company’s telecommunications products and services as well as 297 percent growth in its big data revenue (https://ibn.fm/U0LtZ). Mobile top-up and short and multimedia messaging (SMS and MMS) services have remained the primary drivers of the company’s revenues, serving the interests of China’s estimated 1.4 billion mobile users, most of whom were born after Internet and mobile technology began to develop at a breakneck pace in the 1990s and are now actively the country’s manner of interpersonal communication through social media as “digital natives” (https://ibn.fm/zqkCJ). China’s leading world position as a developer of 5G wireless technology and its use have further made it fertile ground for expanding marketing and purchasing services (https://ibn.fm/a8ocr). Market analysts at Reportlinker.com forecast mobile engagement in China growing at a CAGR of 44.7 percent between 2020 and 2027, commanding $22.4 billion of the global $90.7 billion in revenues predicted by that point (https://ibn.fm/p6PgH). For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Fuelpositive Corp. offers its flagship product, a containerized green ammonia production system which provides environmental-friendly energy solutions across multiple industries
• Company’s green ammonia technology is modular and scalable, and produces green ammonia onsite, thereby eliminating problems posed by highly polluting traditional ammonia production and an unreliable supply chain
• Fuelpositive’s carbon-free NH3 can also play a vital role in enabling the hydrogen economy

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) s a growth-stage technology company engaged in providing energy-efficient solutions that are commercially viable and sustainable. Their flagship product, a containerized green ammonia production system, can be used across a spectrum of industries, with special significance for agricultural fertilizers, and offers innovative solutions that address environmental concerns and unpredictable supply chain risks. FuelPositive’s containerized green ammonia production system was developed by Dr. Ibrahim Dincer and his team at the University of Ontario Institute of Technology (“UOIT”)  (patent-pending). The ammonia is manufactured onsite from water and air, using a sustainable electricity source – thereby producing green ammonia that is entirely carbon-free. The system is modular, scalable, and fits in standard shipping containers that are placed where the green ammonia is needed. This decentralized approach avoids the hurdles posed by the unreliable supply chain and wildly fluctuating prices that end users have been struggling with over recent years. Users produce green ammonia when and where they want, in the right quantities. This mechanism is ideal for the fertilizer industry, where more than 80% of the world’s ammonia is used. FuelPositive Corp. has filed a U.S. Non-Provisional Patent Application for the company’s “Modular Transportable Clean Hydrogen-Ammonia Maker” with the United States Patent and Trademark Office. FuelPositive has also filed a companion Patent Co-Operation Treaty (“PCT”) Patent Application preserving FuelPositive’s right to its proprietary invention in all 156 PCT member states (https://ibn.fm/g1UQ9). FuelPositive’s demonstration units are being built to produce up to 300 kg/day, which is enough to provide fertilizer and fuel to thousands of acres of agricultural lands. The company’s first demonstration production system will be set up in Manitoba, Canada in fall 2022. Similar demonstration pilot projects will follow. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Flora just announced the repurchase of $5 million of its outstanding common shares
• This repurchase aligns with its overall global expansion plan, and its move to grow its market reach
• These moves by Flora assure shareholders of the company’s commitment to driving shareholder value and exploring various opportunities to do so

On June 16, 2022, Flora Growth (NASDAQ: FLGC) announced that its Board of Directors had authorized the repurchase of up to $5 million of its outstanding common shares. This came in the wake of the expiration of a one-year lockup period for specific shareholders who had acquired shares before the company’s Initial Public Offering (“IPO”). While making the announcement, Luis Merchan, Flora’s Chairman and Chief Executive Officer (“CEO”), noted: “Flora continues to move assertively to execute its growth plans while simultaneously improving gross profit margins and reducing corporate overhead expenses.” “We are confident in the company’s short, medium, and long-term growth prospects based on our strong in-market brand portfolio together with our cultivation and export capabilities in life sciences research,” he added (https://ibn.fm/maJ87). This move to repurchase shares aligns with Flora’s overall global expansion plan that has seen the company follow through with acquisitions of strategic brands and entities in the industry. For example, earlier in the year, Flora acquired 100% equity interests in Just Brands LLC and High Roller Private Label LLC, the owners of the JustCBD brand, for a consideration of $16 million in cash and 9.5 million in privately issued Flora common shares (https://ibn.fm/pzSTz). The repurchase also aligns with the company’s move to grow its market reach, having announced the expansion of its operational footprint in Europe and the United Kingdom. This expansion would bank on JustCBD’s 79 products registered with the UK Novel Foods, allowing for the distribution of its growing house of brands. At the beginning of the year, Flora’s management reiterated how the cannabis sector was ripe for the picking. Most notably, they noted how great brands and cost advantages are optimal traits for the company’s long-term market leadership and return on investment (“ROI”), emphasizing the opportunities ahead. This outlook is shaping the company’s decision-making process halfway into 2022, even as it seeks to aggressively grow its market reach, product line, and customer numbers. The global cannabidiol (“CBD”) industry is projected to post a CAGR of 21.3% over the forecast period (2021-2028), achieving a value of $47.22 billion, up from $4.9 billion. Flora looks to capitalize on this growth by making strategic acquisitions of key brands in the industry, aggressively expanding its market reach, and taking ownership of its brand, as evidenced by its recent repurchase of outstanding common shares. “The repurchase program affords us the opportunity to increase our ownership in our portfolio of high quality brands through our shares, which in our view, are trading well below NAV,” noted Mr. Merchan. These recent developments highlight Flora’s management’s confidence in where the company is headed and its potential for growth as the year progresses. It also assures shareholders of the company’s commitment to driving shareholder value and exploring various opportunities to do so. As such, this only emphasizes Flora’s value as a good investment. For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• The online gaming sector got its start in 1994, through the launch of Microgaming
• The sector has seen hundreds of online gaming platforms come online in the ensuing decades, with the vast majority opting to white-label their gaming offering from third-party providers
• Golden Matrix Group has sought to cater to this demand through its GMX-Ag platform, providing its customers with access to a portfolio of over 10,000 games
• GMGI’s focus on their white-label business was reflected in the 28% top-line growth seen within their B2B segment in their most recent fiscal quarter

In 1994, a little-known company by the name of Microgaming based in Durban, South Africa would go on to launch what was then, the world’s first online casino – the appropriately named, ‘Gaming Club’ (https://ibn.fm/bNtr3). Debuting at a time when few households boasted an internet connection, much less an affinity to online gambling, Microgaming would go on to spark a revolutionary shift into online gaming, an industry valued as high as $61.5 billion as of 2021 (https://ibn.fm/Rue04). The online gaming industry has spawned hundreds of gambling platforms in the interim since Microgaming took its initial steps within the sector – however, the majority of these have not developed their own games, opting rather to white label product offerings from third party providers whilst devoting their resources on marketing and promotional efforts. Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms and systems, purveying online gaming and gambling platforms, has been a key beneficiary of this trend, providing its end customers with access to a substantial portfolio of upwards of 10,000 games. The growth of the online gaming market has been further boosted by the US Supreme Court’s decision to repeal the Professional and Amateur Sports Protection Act (“PASPA”) in 2018, effectively clearing the way for legalized sports betting across the United States on a federal level. The value of the online gaming market is now expected to surpass the $100 billion mark by 2026, a target which is being accelerated through new inventions and technological advancements –the latter including the likes of Virtual Reality, Internet of Things, Artificial Intelligence, and Augmented Reality. Golden Matrix Group has looked to cater to growing demand from online gaming platforms, most recently through the launch of their B2B aggregate gaming system, GMX-Ag. The turnkey iGaming system seeks to offer online gaming platforms with an optimal casino, sportsbook, and live gaming offering via a single integration with the operators’ existing business systems, whilst simultaneously providing their players with a single, simplified wallet. “The adoption of the GMX-Ag system is both strategic and timely,” said Golden Matrix CEO Brian Goodman (https://ibn.fm/mvGHI). “It expands our B2B offerings to operators in the Asia Pacific (‘APAC’) region, our traditional market, and at the same time opens new market opportunities for Golden Matrix outside of APAC. We expect our growth strategy to expand the GMGI brand and accelerate the company’s global market penetration.” The growth of the online gaming market as well as GMGI’s burgeoning B2B white-labelling business was clearly displayed in the most recent quarter, with Golden Matrix reporting quarterly revenues which rose by 221% year-over-year to $8,482,743 whilst simultaneously recording their 15^th consecutive quarter of profitability. At the time of the results, the Company revealed that the strong results were partly attributable to the robust growth witnessed within their B2B business, with the business vertical seeing its top-line expand by 28% year-over-year. For more information, visit the company’s website at www.GoldenMatrix.com. NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

• Company’s innovative Pluaris offering provides a synthesis of intelligence rather than just a picture of documents to open and read
• NOWG CEO believes the company’s market opportunity is “over $20 billion”
• As the world moves from an information era into a knowledge era, Nowigence gains footholds in both consumer and enterprise markets

Nowigence (OTCQB: NOWG), thae SaaS technology company behind Pluaris, a comprehensive and turnkey AI knowledge engine, and CEO Anoop Bhatia were the focus of a Proactive Investors director interview (https://ibn.fm/1J24y). During the interview, Bhatia provided a brief overview of the company and talked about how its Pluaris offering simplifies the challenges of learning and accelerates the pace of problem solving and decision making, giving Nowigence the means to capitalize on a $20-billion-plus market opportunity. Nowigence Inc. is focused on simplifying the challenges of learning, noted Bhatia, and the company’s name derives from the idea of “now” intelligence. “We are in the field of data intelligence, we are in the field of knowledge management,” he said. Explaining that one of the company’s overarching objectives was to replace keyword search, Bhatia said, “Keyword search doesn’t read the document, doesn’t open documents; it just kind of does a keyword match on the title line of the document. “Our product actually goes into various documents, countless documents, within a few seconds to read the content, answer the question, synthesize the intelligence on a topic that you’re looking for,” Bhatia continued. “And it does it during the time of the search, so it takes about 5 to 20 seconds for you to get a synthesis of intelligence rather than just a picture of documents for you to open and read.” According to Bhatia, Pluaris serves a target audience of knowledge seekers, who could be anyone from students to researchers. “Gartner says there are about a billion knowledge workers from around the world in the English language, and that becomes a market for us on a standalone basis,” Bhatia explained, going on to note that much like “our brain sits on top of our human bodies, Pluaris can also sit on top of various IT tools to read and search for intelligence. So, we do serve the enterprise market too, which is a higher-priced market for us. We process a lot of information for them.” Bhatia stated that the market Pluaris analyzes is huge. “We believe that the market opportunity is over $20 billion,” he noted. “It’s a huge opportunity. It’s an emerging industry that is still seeking a lot of investment dollars. It’s in its early phase of growth. As we become more public, people will recognize and use the product we’ve created. The industry will grow exponentially, as we’re moving from an information era to a knowledge era, and Pluaris helps usher in that knowledge era.” For now, says Bhatia, the company’s strategic plan is to grow commercially. “The product is very unique, a very differentiated product from the rest of the market,” he said. “We’ve already got footholds in both the consumer market and the enterprise market, so we do intend to grow the company, but we also intend to continue to invest in this product.” Nowigence is an innovative software as a service (“SaaS”) company, focused on developing and bringing to market Pluaris, its comprehensive, ready-to-use artificial-intelligence platform. By integrating state-of-the-art data processing techniques in an intuitive interface at an affordable subscription price, Pluaris puts the power of data science into the hands of consumers. For more information, visit the company’s website at www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to NOWG are available in the company’s newsroom at https://ibn.fm/NOWG

• Music artists often find that major labels do not provide them with the support they need as an artist and are put off by the excessive fees taken for production, distribution, and promotion of music
• Fan Pass Live is now the ultimate 360-degree anti-label offering for musicians, allowing them to keep control of their music and receive higher revenue
• Fan Pass Live offers musicians the tools necessary to produce, distribute, and promote their music without hefty fees or loss of ownership, while also providing artists additional means of revenue through monthly contests

When an artist signs with a music label, most are required to assign the master rights of their songs to the label. The label is then responsible for duplicating, distributing, and marketing the recordings on behalf of the artist. Labels then earn revenue from the artist’s music when it is sold, performed, or used under master licensing. The amount of control the label has over the artist’s career and earnings has become a serious topic amongst independent artists looking to produce, distribute, and promote their music. Friendable (OTC: FDBL), a mobile technology and marketing company focused on developing and identifying products, services, and brand opportunities with mass market potential and scalability, is addressing this concern and opening doors for independent music artists through its flagship offering, Fan Pass Live, and acquired platforms Artist Republik and FeaturedX. The company’s presentation discusses the fees associated with traditional label control on a music artist’s offering (https://ibn.fm/xiv93). According to Friendable, on average, a music artist loses 90% of streaming revenue to labels, 10% to booking agents, and 15-20% of overall income to managers. Artists are not only losing revenue to the companies they entrust to produce, distribute, and promote their music but also feel a lack of support overall from the operation. With roots well established in the art of music, Friendable’s management, brothers Robert A. Rositano Jr. and Dean Rositano, set out on a mission to disrupt the music industry’s landscape. The Fan Pass Live artist platform was released in July 2020, when music venues were closing due to the pandemic. The platform’s initial offering was to provide a virtual stage where independent artists could perform for fans without needing to leave home. In January 2022, the company took one more step toward supporting these artists by acquiring Artist Republik and FeaturedX. When artists sign up for Fan Pass Live, they are given a 360-degree artist experience, free from label control with the tools necessary to produce, distribute, and promote their music without paying the excessive fees associated with label control. Through the Fan Pass Live artist platform, independent musicians now have access to:

• Music distribution and management
• Music production assistance
• Press release and Instagram promotion
• Digital storefront activation
• Artist marketplace for collaborations
• Merch, logo, and promotion design support
• Virtual concert booking and ticketing mobile streaming service
• Live streaming support
• Revenue from fan tips, monthly artist contests, merchandise, and ticket sales
• Access to fan data and performance analytics
• Monthly artist contests
• NFT development and Metaverse – coming soon

The services provided by Fan Pass Live, Artist Republik, and FeaturedX allow artists to do what they love without losing the revenue for doing it. In addition to production, distribution, and promotion efforts, artists also get to enjoy monthly contests put on by Fan Pass Live. The most recent contest for the month of June awards merchandise design packages to the top three artists with the most online tips for the month. In addition to the main contest, artists who schedule streams on the Fan Pass calendar get featured in the weekly Fan & Artist newsletter. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• LQwD currently has Lightning Network nodes in 17 countries with a goal of 24 by the end of Q4 2022
• The current LQwD nodes have already processed over 10k transactions, and the number is climbing
• The global cryptocurrency market was valued at US $1.49 billion in 2020. The market is projected to reach US $4.94 billion by 2030, growing at a CAGR of 12.8%

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) continues to move forward with its endeavors on the Bitcoin Lightning Network. The company currently has active nodes spanning 17 countries, including the U.S., Ireland, India, Germany, Brazil, Hong Kong, Singapore, Sweden, South Korea, South Africa, Bahrain, Indonesia, Italy, France, Canada, England, and Japan. These nodes range in capacity from 0.050000000 BTC to 5.700269470 BTC. The longest running node within the company’s selection is US-West, released in November 2021. LQwD’s mission is to offer platform-as-a-service (“PaaS”) for the Lightning Network nodes and payment channels, be a network service provider that offers routing and liquidity services, and accumulate Bitcoin as a treasury reserve asset for staking and liquidity. The company’s flagship PaaS offering, https://lqwd.tech/, was released in November 2021. The PaaS features a sophisticated backend functionality and was designed to be scalable and flexible, positioning needed for the growth of the network. The LQwD Board currently consists of Shone Anstey, Ashley Garnot, Pino Perone, and Kim Evans (https://ibn.fm/Huddc). Shone Anstey is the Chairman and CEO of LQwD. He has over 20 years of experience building complex technologies and software. He has worked with cryptocurrency since 2012 and acted as a technology lead for an industrial Bitcoin mining and mining pool. Shone’s experience in cryptocurrency has afforded him titles of Certified Bitcoin Professional and Certified Cryptocurrency Investigator. Ashley Garnot is currently in charge of corporate communications and brand awareness programs for TSX-listed TAG Oil, Ltd. Her completion of the Canadian Securities Course, her strategic problem-solving skills, and broad knowledge of US and Canadian corporate and board-level relationships have made her an asset to the LQwD Board. She also holds an advanced merchandising diploma. Pino Perone is LQwD’s Corporate Secretary and has more than a decade of experience serving as an executive and director for private and publicly listed companies. He is a lawyer by trade with expertise spanning securities, corporate commercial, M&A, capital market matters, regulatory compliance, and corporate governance. Kim Evans is a CPA with extensive experience in the corporate securities, junior mining, and technology sectors. She has over two decades of experience in directorial and officer roles for publicly listed companies on the Canadian Exchange. As LQwD presses forward to become a top liquidity service provider, the knowledge and experience of the board will prove crucial to its efforts. By the end of Q4 2022, LQwD hopes to have active nodes in 24 countries worldwide (https://ibn.fm/SpE5i). The current nodes have already facilitated over 10k transactions and are climbing. As a publicly traded company, LQwD hopes to enhance public trust in the products and services to scale the Lightning Network as a premier cryptocurrency transaction platform. According to Allied Market Research, the global cryptocurrency market size was valued at US $1.49 billion in 2020. The market is projected to reach US $4.94 billion by 2030, growing at a CAGR of 12.8%. Driving factors for cryptocurrency adoption are operational efficiency, transparency, and the rise in demand for remittances in developing countries (https://ibn.fm/43tXm). For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF